Page 18 - Read Online

Page 14 of 14 Santoni et al. J Cancer Metastasis Treat 2020;6:22 I http://dx.doi.org/10.20517/2394-4722.2020.49

72. Lee HC, Kang D, Han N, Lee Y, Hwang HJ, et al. A novel long noncoding RNA Linc-ASEN represses cellular senescence through
multileveled reduction of p21 expression. Cell Death Differ 2020;27:1844-61.
73. Yang J, Gan X, Tan B, Wang J, Chen Y. Corticotropin-releasing factorsuppresses glioma progression by upregulation of long non-coding
RNA-p21. Life Sci 2019;216:92-100.
74. He Y, Meng XM, Huang C, Wu BM, Zhang L, et al. Long noncoding RNAs: novel insights into hepatocelluar carcinoma. Cancer Lett
2014;344:20-7.
75. Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell 2016;29:452-63.
76. Heery R, Finn SP, Cuffe S, Gray SG. Long non-coding RNAs: key regulators of epithelial-mesenchymal transition, tumour drug
resistance and cancer stem cells. Cancers (Basel) 2017;9:38.
77. Huang W, Zhong Z, Luo C, Xiao Y, Li L, et al. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and
temozolomide resistance in glioma. Theranostics 2019;9:5497-516.
78. Wu P, Cai J, Chen Q, Han B, Meng X, et al. Lnc-TALC promotes O 6-methylguanine-DNA methyltransferase expression via regulating
the c-Met pathway by competitively binding with miR-20b-3p. Nat Commun 2019;10:2045.
79. Zhang Y, Dutta A, Abounader R. The role of microRNAs in glioma initiation and progression. Front Biosci 2012;17:700-12.
80. Sana J, Hajduch M, Michalek J, Vyzula R, Slaby O. MicroRNAs and glioblastoma: roles in core signalling pathways and potential clinical
implications. J Cell Mol Med 2011;15:1636-44.